- Home
- ANL vs FSEA Comparison
ANL vs FSEA Comparison
Compare ANL & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANL
- FSEA
- Stock Information
- Founded
- ANL 2004
- FSEA 1890
- Country
- ANL Cayman Islands
- FSEA United States
- Employees
- ANL N/A
- FSEA N/A
- Industry
- ANL
- FSEA Savings Institutions
- Sector
- ANL
- FSEA Finance
- Exchange
- ANL Nasdaq
- FSEA Nasdaq
- Market Cap
- ANL 61.8M
- FSEA 53.7M
- IPO Year
- ANL 2023
- FSEA N/A
- Fundamental
- Price
- ANL $1.79
- FSEA $11.51
- Analyst Decision
- ANL Hold
- FSEA
- Analyst Count
- ANL 1
- FSEA 0
- Target Price
- ANL N/A
- FSEA N/A
- AVG Volume (30 Days)
- ANL 11.6K
- FSEA 2.9K
- Earning Date
- ANL 09-23-2025
- FSEA 11-07-2025
- Dividend Yield
- ANL N/A
- FSEA N/A
- EPS Growth
- ANL N/A
- FSEA N/A
- EPS
- ANL N/A
- FSEA N/A
- Revenue
- ANL N/A
- FSEA $14,095,000.00
- Revenue This Year
- ANL N/A
- FSEA N/A
- Revenue Next Year
- ANL N/A
- FSEA N/A
- P/E Ratio
- ANL N/A
- FSEA N/A
- Revenue Growth
- ANL N/A
- FSEA 30.26
- 52 Week Low
- ANL $1.10
- FSEA $8.90
- 52 Week High
- ANL $3.89
- FSEA $11.95
- Technical
- Relative Strength Index (RSI)
- ANL 60.76
- FSEA 49.54
- Support Level
- ANL $1.65
- FSEA $11.51
- Resistance Level
- ANL $1.91
- FSEA $11.74
- Average True Range (ATR)
- ANL 0.10
- FSEA 0.12
- MACD
- ANL 0.00
- FSEA -0.01
- Stochastic Oscillator
- ANL 58.02
- FSEA 15.22
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities, and bank-owned life insurance.